Almeida, O.L.S.; Ferriolli, E.; Taveira, R.C.C.; Rosenburg, M.G.; Campanari, D.D.; da Cruz Alves, N.M.; Pfrimer, K.; Rapatoni, L.; Peria, F.M.; Lima, N.K.C.
Mirtazapine versus Megestrol in the Treatment of Anorexia–Cachexia Syndrome in Patients with Advanced Cancer: A Randomized, Double-Blind, Controlled Phase II Clinical Trial. Cancers 2023, 15, 3588.
https://doi.org/10.3390/cancers15143588
AMA Style
Almeida OLS, Ferriolli E, Taveira RCC, Rosenburg MG, Campanari DD, da Cruz Alves NM, Pfrimer K, Rapatoni L, Peria FM, Lima NKC.
Mirtazapine versus Megestrol in the Treatment of Anorexia–Cachexia Syndrome in Patients with Advanced Cancer: A Randomized, Double-Blind, Controlled Phase II Clinical Trial. Cancers. 2023; 15(14):3588.
https://doi.org/10.3390/cancers15143588
Chicago/Turabian Style
Almeida, Olga Laura Sena, Eduardo Ferriolli, Roberta Cristina Cintra Taveira, Meire Gallo Rosenburg, Daniela Dalpubel Campanari, Natália Maira da Cruz Alves, Karina Pfrimer, Liane Rapatoni, Fernanda Maris Peria, and Nereida K. C. Lima.
2023. "Mirtazapine versus Megestrol in the Treatment of Anorexia–Cachexia Syndrome in Patients with Advanced Cancer: A Randomized, Double-Blind, Controlled Phase II Clinical Trial" Cancers 15, no. 14: 3588.
https://doi.org/10.3390/cancers15143588
APA Style
Almeida, O. L. S., Ferriolli, E., Taveira, R. C. C., Rosenburg, M. G., Campanari, D. D., da Cruz Alves, N. M., Pfrimer, K., Rapatoni, L., Peria, F. M., & Lima, N. K. C.
(2023). Mirtazapine versus Megestrol in the Treatment of Anorexia–Cachexia Syndrome in Patients with Advanced Cancer: A Randomized, Double-Blind, Controlled Phase II Clinical Trial. Cancers, 15(14), 3588.
https://doi.org/10.3390/cancers15143588
